, Mahalul Azam2
, Endang Sri Wahjuni3
, Ronal Surya Aditya4
, Reem Lafi AlMutairi5
, Supriyadi Supriyadi1
1Department of Medicine, Faculty of Medicine, Universitas Negeri Malang, Malang, Indonesia
2Department of Public Health, Faculty of Medicine, Universitas Negeri Semarang, Semarang, Indonesia
3Department of Medicine, Faculty of Medicine, Universitas Negeri Surabaya, Surabaya, Indonesia
4Department of Nursing, Faculty of Nursing, Universitas Jember, Jember, Indonesia
5Department of Public Health, College of Public Health and Health Informatics, University of Hail, Hail, Saudi Arabia
Copyright © 2026 The Korean Society for Preventive Medicine
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Conflict of Interest
The authors have no conflicts of interest associated with the material presented in this paper.
Funding
None.
Acknowledgements
None.
Author Contributions
Conceptualization: Yunus M, Azam M. Formal analysis: Aditya RS, Azam M. Funding acquisition: None. Methodology: Yunus M, Wahjuni ES, Aditya RS. Visualization: Azam M, Aditya RS. Writing – original draft: Yunus M, Supriyadi S. Writing – review & editing: Yunus M, Azam M, Wahjuni ES, Aditya RS, AlMutairi RL, Supriyadi S.
ASEAN, Association of Southeast Asian Nations; GDP, gross domestic product; USD, US dollar; PPP, purchasing power parity; UHC, universal health coverage.
1 Missing data (2.1–6.4%) were handled via multiple imputation by chained equations (m=20).
Sources from: World Bank Open Data (2023), United Nations Sustainable Development Goals Database (2023), and World Health Organization Global Health Observatory (2023).
NCD, non-communicable disease; DALY, disability-adjusted life year; CI, confidence interval; SE, standard error; UHC, universal health coverage; GDP, gross domestic product; PPP, purchasing power parity.
1 All models used two-way fixed effects (country and year) and Driscoll–Kraay standard errors to account for heteroskedasticity and cross-sectional dependence; The primary and secondary outcome models were adjusted for GDP per capita (PPP), urbanization rate (%), and health expenditure per capita; The interaction model additionally included the UHC index and the physical inactivity×UHC index term; The UHC index was rescaled to 10-point units in the interaction model; For the main effects, β coefficients represent the estimated change in the outcome associated with a one-percentage-point increase in physical inactivity prevalence; For the interaction term, the β coefficient represents the change in the association between physical inactivity and NCD burden for each 10-point increase in the UHC index, rather than the effect of a one-percentage-point increase in physical inactivity itself; For the interaction term, because the UHC index was rescaled to 10-point units, the coefficient (β=−0.183) represents the absolute change in the physical inactivity slope (in DALYs per 100 000 population) for each 10-point increase in the UHC index, rather than a relative percentage reduction.
NCD, non-communicable disease; DALYs, disability-adjusted life years per 100 000 population; CI, confidence interval; LL, lower limit; UL, upper limit; MAE, mean absolute error; SHAP, Shapley additive explanations; GDP, gross domestic product.
1 XGBoost model: training 2010–2018 (n=45), validation 2019–2021 (n=15); Model validation: MAE=1830 DALYs per 100 000 population; R2=0.847; Top predictors by SHAP: physical inactivity prevalence (1.847), GDP growth rate (1.423), Universal health coverage index (1.218); 95% CIs represent the lower and upper limits of the projected percentage change (Δ) derived from 1000 bootstrap resamples; Priority level classification is exploratory and was defined post hoc based on the projected percentage change (Δ) in NCD-related DALYs: high (≥15.0%), moderate (8.0 to <15.0%), and low (<8.0%); These thresholds are intended solely for exploratory scenario planning and do not represent prespecified, validated clinical or epidemiological cutoffs.
| Characteristics | Indonesia | Malaysia | Thailand | Philippines | Vietnam |
|---|---|---|---|---|---|
| Population (million, 2021) | 273.5 | 32.4 | 69.8 | 109.6 | 97.3 |
| Urbanization rate (%) | |||||
| 2010 | 50.2 | 70.8 | 46.4 | 47.3 | 30.5 |
| 2021 | 57.3 | 77.2 | 52.2 | 47.8 | 38.4 |
| Change (%) | +14.1 | +9.0 | +12.5 | +1.1 | +25.9 |
| GDP per capita (PPP, 2017 USD) | |||||
| 2010 | 8920 | 22 180 | 13 540 | 6340 | 4210 |
| 2021 | 12 450 | 28 760 | 18 920 | 8670 | 9540 |
| Change (%) | +39.6 | +29.7 | +39.7 | +36.8 | +126.8 |
| Health expenditure per capita (PPP, USD) | |||||
| 2010 | 287 | 891 | 542 | 198 | 142 |
| 2021 | 412 | 1247 | 789 | 287 | 398 |
| Physician density (per 10 000) | |||||
| 2010 | 2.8 | 14.2 | 7.9 | 5.3 | 7.1 |
| 2021 | 4.3 | 16.8 | 9.4 | 6.7 | 9.8 |
| UHC Service Coverage Index (0–100) | |||||
| 2010 | 48 | 68 | 73 | 47 | 64 |
| 2021 | 57 | 76 | 80 | 56 | 74 |
| Life expectancy at birth (year) | |||||
| 2010 | 69.2 | 74.1 | 74.8 | 68.9 | 75.2 |
| 2021 | 69.8 | 75.0 | 77.2 | 69.4 | 75.4 |
| Variables | β coefficient (95% CI) | SE | p-value | Adjusted R2 |
|---|---|---|---|---|
| Primary outcome | ||||
| NCD DALYs per 100 000 | 0.421 (0.251, 0.591) | 0.087 | <0.001 | 0.68 |
| Secondary outcomes | ||||
| Cardiovascular mortality per 100 000 | 0.318 (0.193, 0.443) | 0.064 | <0.001 | 0.61 |
| Diabetes prevalence (%) | 0.274 (0.160, 0.388) | 0.058 | 0.002 | 0.57 |
| NCD mortality per 100 000 | 0.389 (0.221, 0.557) | 0.085 | <0.001 | 0.64 |
| Interaction analysis for NCD DALYs | ||||
| Physical inactivity×UHC index | −0.183 (−0.358, −0.008) | 0.089 | 0.041 | 0.71 |
| Country | DALYs 2021 (actual) | Projected DALYs 2025 | Δ (%) | 95% CI for Δ (%) | Priority level | |
|---|---|---|---|---|---|---|
| LL | UL | |||||
| Indonesia | 21 712 | 25 480 | +17.3 | 13.8 | 20.8 | High |
| Malaysia | 14 105 | 15 630 | +10.8 | 7.9 | 13.7 | Moderate |
| Thailand | 14 726 | 15 870 | +7.8 | 5.1 | 10.5 | Low |
| Philippines | 20 570 | 24 890 | +20.9 | 17.2 | 24.6 | High |
| Vietnam | 15 420 | 16 840 | +9.2 | 6.3 | 12.1 | Moderate |
ASEAN, Association of Southeast Asian Nations; GDP, gross domestic product; USD, US dollar; PPP, purchasing power parity; UHC, universal health coverage. Missing data (2.1–6.4%) were handled via multiple imputation by chained equations (m=20). Sources from: World Bank Open Data (2023), United Nations Sustainable Development Goals Database (2023), and World Health Organization Global Health Observatory (2023).
NCD, non-communicable disease; DALY, disability-adjusted life year; CI, confidence interval; SE, standard error; UHC, universal health coverage; GDP, gross domestic product; PPP, purchasing power parity. All models used two-way fixed effects (country and year) and Driscoll–Kraay standard errors to account for heteroskedasticity and cross-sectional dependence; The primary and secondary outcome models were adjusted for GDP per capita (PPP), urbanization rate (%), and health expenditure per capita; The interaction model additionally included the UHC index and the physical inactivity×UHC index term; The UHC index was rescaled to 10-point units in the interaction model; For the main effects, β coefficients represent the estimated change in the outcome associated with a one-percentage-point increase in physical inactivity prevalence; For the interaction term, the β coefficient represents the change in the association between physical inactivity and NCD burden for each 10-point increase in the UHC index, rather than the effect of a one-percentage-point increase in physical inactivity itself; For the interaction term, because the UHC index was rescaled to 10-point units, the coefficient (β=−0.183) represents the absolute change in the physical inactivity slope (in DALYs per 100 000 population) for each 10-point increase in the UHC index, rather than a relative percentage reduction.
NCD, non-communicable disease; DALYs, disability-adjusted life years per 100 000 population; CI, confidence interval; LL, lower limit; UL, upper limit; MAE, mean absolute error; SHAP, Shapley additive explanations; GDP, gross domestic product. XGBoost model: training 2010–2018 (n=45), validation 2019–2021 (n=15); Model validation: MAE=1830 DALYs per 100 000 population;